Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Observational × lorlatinib × Clear all

Status

Completed 5 Recruiting 2 Active not recruiting 2 Terminated 1 Not yet recruiting 1 Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 4 Observational 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

Observation 17 Blood Specimen Collection 13 Surveys and Questionnaires 12 Drug Therapy 11 Immune Checkpoint Inhibitors 7 Surgical Procedures, Operative 6 Neoadjuvant Therapy 6 Watchful Waiting 5 Docetaxel 5 Positron Emission Tomography Computed Tomography 4 Fluorodeoxyglucose F18 4 Bevacizumab 4 envafolimab 3 darolutamide 3 Radiotherapy 3 Radiofrequency Ablation 3 Radiation 3 Letrozole 3 Interviews as Topic 3 Indocyanine Green 3 Hematologic Tests 3 Endoscopic Mucosal Resection 3 tislelizumab 2 pertuzumab 2 palbociclib 2 obinutuzumab 2 neratinib 2 camrelizumab 2 Ultrasonography 2 Tyrosine Kinase Inhibitors 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06690541 2024-11-15

COMLORLA

Peking University Cancer Hospital & Institute

Not yet recruiting

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡